Medlines https://www.medlinespod.com en © 2026 Human Content, Inc. and Glaucomflecken, LLC. All rights reserved. Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know.  Medicine moves fast... So do we!  Learn More: www.medlinespod.com Medlines is A Human Content Production https://megaphone.imgix.net/podcasts/2e5f4cc4-73ff-11f1-a987-0796a5595ecc/image/7cba2e1a09eb4fc291f5d12ad36d6c70.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Medlines https://www.medlinespod.com no episodic Healthcare News on the Go Human Content, Inc. Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know.  Medicine moves fast... So do we!  Learn More: www.medlinespod.com Medlines is A Human Content Production Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.)

Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals.

Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know. 

Medicine moves fast... So do we! 


Learn More: www.medlinespod.com


Medlines is A Human Content Production

]]> Human Content, Inc. hello@medlinespod.com FDA Approves mRNA Flu Shot and AI Learns to Build Viruses Friday, August 14, 2026 In today's episode, Adam Rose (@adjoro) & Dr. Alok Patel (@alokpatelmd) cover the FDA's landmark approval of Moderna's first mRNA flu vaccine for adults. They break down the phase-three trial showing the mRNA shot produced fewer confirmed influenza cases than standard vaccines, and what a complicated insurance landscape means for access this flu season. Plus: researchers at the Arc Institute fed millions of viral DNA sequences to a language model. It wrote new genomes that had never existed in nature, and sixteen of them came to life in the lab. Then, they look at a new narcolepsy drug targeting the underlying orexin deficiency, a Salmonella outbreak linked to jalapeños spreading through 27 states, and over 2,400 measles cases putting U.S. elimination status in jeopardy. (0:00) Intro (1:01) First mRNA Flu Vaccine Approved (4:52) AI Designs Functional Viruses (8:54) Salmonella Jalapeño Outbreak (9:44) Measles Resurgence (10:04) Women's Pro Baseball Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.  Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources  Medlines is a Human Content Production Fri, 14 Aug 2026 10:00:00 -0000 full 7 Human Content, Inc. Friday, August 14, 2026 In today's episode, Adam Rose (@adjoro) & Dr. Alok Patel (@alokpatelmd) cover the FDA's landmark approval of Moderna's first mRNA flu vaccine for adults. They break down the phase-three trial showing the mRNA shot produced fewer confirmed influenza cases than standard vaccines, and what a complicated insurance landscape means for access this flu season. Plus: researchers at the Arc Institute fed millions of viral DNA sequences to a language model. It wrote new genomes that had never existed in nature, and sixteen of them came to life in the lab. Then, they look at a new narcolepsy drug targeting the underlying orexin deficiency, a Salmonella outbreak linked to jalapeños spreading through 27 states, and over 2,400 measles cases putting U.S. elimination status in jeopardy. (0:00) Intro (1:01) First mRNA Flu Vaccine Approved (4:52) AI Designs Functional Viruses (8:54) Salmonella Jalapeño Outbreak (9:44) Measles Resurgence (10:04) Women's Pro Baseball Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.  Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources  Medlines is a Human Content Production Friday, August 14, 2026

In today's episode, Adam Rose (@adjoro) & Dr. Alok Patel (@alokpatelmd) cover the FDA's landmark approval of Moderna's first mRNA flu vaccine for adults. They break down the phase-three trial showing the mRNA shot produced fewer confirmed influenza cases than standard vaccines, and what a complicated insurance landscape means for access this flu season. Plus: researchers at the Arc Institute fed millions of viral DNA sequences to a language model. It wrote new genomes that had never existed in nature, and sixteen of them came to life in the lab. Then, they look at a new narcolepsy drug targeting the underlying orexin deficiency, a Salmonella outbreak linked to jalapeños spreading through 27 states, and over 2,400 measles cases putting U.S. elimination status in jeopardy.


(0:00) Intro

(1:01) First mRNA Flu Vaccine Approved

(4:52) AI Designs Functional Viruses

(8:54) Salmonella Jalapeño Outbreak

(9:44) Measles Resurgence

(10:04) Women's Pro Baseball

Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. 

Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources 

Medlines is a Human Content Production

]]> 779 no Our Blood Donation Crisis & An Organ Transplant First August 7, 2026 In today's episode, Dr. Will Flanary (@DrGlaucomflecken) & Eva Johnson cover the American Red Cross declaring its second-ever national blood crisis, with Type O blood critically low and hospitals postponing transfusions. They break down what's driving the shortage and debate whether blood donors deserve HOV-lane perks. Then: a 36-year-old Iowa woman with cystic fibrosis becomes the first known U.S. patient to receive a quadruple organ transplant involving re-transplanted lungs, in addition to a liver and kidney, at Northwestern Medicine.  Plus: Florida advises caution on psychiatric medication for children, a promising non-opioid pain drug (LTG-001) reduces opioid use after surgery, and Will reveals whether he actually knows his blood type. Coverage Timeline: (0:00) Intro & Trivia Question (1:00) Red Cross Blood Crisis (3:54) Should We Pay Blood Donors? (4:44) Historic 4-Organ Transplant (8:32) Florida Psych Meds Debate (10:04) Non-Opioid Pain Relief Trial Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Fri, 07 Aug 2026 10:00:00 -0000 full 6 Human Content, Inc. August 7, 2026 In today's episode, Dr. Will Flanary (@DrGlaucomflecken) & Eva Johnson cover the American Red Cross declaring its second-ever national blood crisis, with Type O blood critically low and hospitals postponing transfusions. They break down what's driving the shortage and debate whether blood donors deserve HOV-lane perks. Then: a 36-year-old Iowa woman with cystic fibrosis becomes the first known U.S. patient to receive a quadruple organ transplant involving re-transplanted lungs, in addition to a liver and kidney, at Northwestern Medicine.  Plus: Florida advises caution on psychiatric medication for children, a promising non-opioid pain drug (LTG-001) reduces opioid use after surgery, and Will reveals whether he actually knows his blood type. Coverage Timeline: (0:00) Intro & Trivia Question (1:00) Red Cross Blood Crisis (3:54) Should We Pay Blood Donors? (4:44) Historic 4-Organ Transplant (8:32) Florida Psych Meds Debate (10:04) Non-Opioid Pain Relief Trial Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production August 7, 2026

In today's episode, Dr. Will Flanary (@DrGlaucomflecken) & Eva Johnson cover the American Red Cross declaring its second-ever national blood crisis, with Type O blood critically low and hospitals postponing transfusions. They break down what's driving the shortage and debate whether blood donors deserve HOV-lane perks. Then: a 36-year-old Iowa woman with cystic fibrosis becomes the first known U.S. patient to receive a quadruple organ transplant involving re-transplanted lungs, in addition to a liver and kidney, at Northwestern Medicine.  Plus: Florida advises caution on psychiatric medication for children, a promising non-opioid pain drug (LTG-001) reduces opioid use after surgery, and Will reveals whether he actually knows his blood type.


Coverage Timeline:

(0:00) Intro & Trivia Question

(1:00) Red Cross Blood Crisis

(3:54) Should We Pay Blood Donors?

(4:44) Historic 4-Organ Transplant

(8:32) Florida Psych Meds Debate

(10:04) Non-Opioid Pain Relief Trial


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.


Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources


Medlines is a Human Content Production

]]> 826 no The ChatGPT Medical Lawsuit & Why Statin Rules Just Changed Friday, July 31, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a Florida man's lawsuit against OpenAI after ChatGPT repeatedly dismissed his pulmonary embolism symptoms as "not something dangerous." The case raises urgent questions about AI medical liability just as a new JAMA analysis reveals updated cholesterol guidelines now make 87.5 million US adults eligible for statins (more than 56% of the 30-to-79 population). Plus: they also discuss the FDA's first dual-ingredient OTC pain reliever, Lego MRI models cutting pediatric sedation rates by nearly half, and Europe's approval of a retinal implant that helped 84% of participants read again. Plus: oral GLP-1 competition heats up and a new smell-impairment and depression link. (00:00) Intro & Trivia Question (01:05) AI Medical Advice Lawsuit (OpenAI/ChatGPT) (04:34) New Cholesterol Guidelines & Statin Eligibility (07:05) Off The Clock GLP-1s, Lego MRI, OTC Pain Combo (11:03) Trivia Answer Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Fri, 31 Jul 2026 10:00:00 -0000 full 5 Human Content, Inc. Friday, July 31, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a Florida man's lawsuit against OpenAI after ChatGPT repeatedly dismissed his pulmonary embolism symptoms as "not something dangerous." The case raises urgent questions about AI medical liability just as a new JAMA analysis reveals updated cholesterol guidelines now make 87.5 million US adults eligible for statins (more than 56% of the 30-to-79 population). Plus: they also discuss the FDA's first dual-ingredient OTC pain reliever, Lego MRI models cutting pediatric sedation rates by nearly half, and Europe's approval of a retinal implant that helped 84% of participants read again. Plus: oral GLP-1 competition heats up and a new smell-impairment and depression link. (00:00) Intro & Trivia Question (01:05) AI Medical Advice Lawsuit (OpenAI/ChatGPT) (04:34) New Cholesterol Guidelines & Statin Eligibility (07:05) Off The Clock GLP-1s, Lego MRI, OTC Pain Combo (11:03) Trivia Answer Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Friday, July 31, 2026

In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a Florida man's lawsuit against OpenAI after ChatGPT repeatedly dismissed his pulmonary embolism symptoms as "not something dangerous." The case raises urgent questions about AI medical liability just as a new JAMA analysis reveals updated cholesterol guidelines now make 87.5 million US adults eligible for statins (more than 56% of the 30-to-79 population). Plus: they also discuss the FDA's first dual-ingredient OTC pain reliever, Lego MRI models cutting pediatric sedation rates by nearly half, and Europe's approval of a retinal implant that helped 84% of participants read again. Plus: oral GLP-1 competition heats up and a new smell-impairment and depression link.


(00:00) Intro & Trivia Question

(01:05) AI Medical Advice Lawsuit (OpenAI/ChatGPT)

(04:34) New Cholesterol Guidelines & Statin Eligibility

(07:05) Off The Clock GLP-1s, Lego MRI, OTC Pain Combo

(11:03) Trivia Answer


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com


Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources


Medlines is a Human Content Production

]]> 849 no Kalshi Prediction Market and CMS's 2027 Fee Schedule Overhaul Friday, July 24, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover CMS's sweeping 2027 physician fee schedule proposal, which would accelerate Medicare's shift from fee-for-service toward value-based, preventive care. They also unpack Kalshi's launch of clinical trial prediction markets; betting on FDA approvals is now a real thing, and the ethical questions are piling up. Coffee gets a heart health endorsement from the AHA, and an outbreak of Legionnaires' disease hits Manhattan's Upper East Side. Last, but far from least, we discuss the FDA's transparency whiplash on rejection letters, the first RCT of a ketogenic diet for severe mental illness, and more. Coverage Timeline: (00:00) Intro & Trivia Question (01:17) Medicare Physician Payment Overhaul (04:30) Prediction Markets for Clinical Trials (07:12) Off the Clock: FDA, Coffee, Outbreak, Ketogenic Diet (09:57) Trivia Answer (11:07) Outro & Disclaimers Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Fri, 24 Jul 2026 10:00:00 -0000 full 4 Human Content, Inc. Friday, July 24, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover CMS's sweeping 2027 physician fee schedule proposal, which would accelerate Medicare's shift from fee-for-service toward value-based, preventive care. They also unpack Kalshi's launch of clinical trial prediction markets; betting on FDA approvals is now a real thing, and the ethical questions are piling up. Coffee gets a heart health endorsement from the AHA, and an outbreak of Legionnaires' disease hits Manhattan's Upper East Side. Last, but far from least, we discuss the FDA's transparency whiplash on rejection letters, the first RCT of a ketogenic diet for severe mental illness, and more. Coverage Timeline: (00:00) Intro & Trivia Question (01:17) Medicare Physician Payment Overhaul (04:30) Prediction Markets for Clinical Trials (07:12) Off the Clock: FDA, Coffee, Outbreak, Ketogenic Diet (09:57) Trivia Answer (11:07) Outro & Disclaimers Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Friday, July 24, 2026

In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover CMS's sweeping 2027 physician fee schedule proposal, which would accelerate Medicare's shift from fee-for-service toward value-based, preventive care. They also unpack Kalshi's launch of clinical trial prediction markets; betting on FDA approvals is now a real thing, and the ethical questions are piling up. Coffee gets a heart health endorsement from the AHA, and an outbreak of Legionnaires' disease hits Manhattan's Upper East Side. Last, but far from least, we discuss the FDA's transparency whiplash on rejection letters, the first RCT of a ketogenic diet for severe mental illness, and more.


Coverage Timeline:

(00:00) Intro & Trivia Question

(01:17) Medicare Physician Payment Overhaul

(04:30) Prediction Markets for Clinical Trials

(07:12) Off the Clock: FDA, Coffee, Outbreak, Ketogenic Diet

(09:57) Trivia Answer

(11:07) Outro & Disclaimers


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com


Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources


Medlines is a Human Content Production

]]> 766 Aspirin vs. Blood Thinners, a 9-Year Endo Wait Ends & Cyclospora Hits Taco Bell Friday, July 17, 2026 In today’s episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) and Adam Rose cover the EPCAT III trial, which found that aspirin alone was non-inferior to an initial course of rivaroxaban followed by aspirin for preventing major blood clots after elective hip or knee replacement in predominantly standard-risk patients. They examine NICE’s draft recommendation allowing two rapid endometriosis tests, EndoSure and Endotest, to enter limited NHS use while researchers gather additional real-world evidence. Plus: They discuss a recall involving more than 2.5 million bottles of prednisolone acetate eye drops, the first HAVANA Act compensation payments, the expanding Cyclospora response, and The Pitt leading the 2026 Emmy nominations with 25 nods. (00:00) Intro (01:07) Aspirin vs. Rivaroxaban After Joint Replacement (03:19) NICE Endorses Rapid Endometriosis Tests (05:30) FDA Recall of Prednisolone Eye Drops (06:07) First Havana Syndrome Payments (06:41) Cyclospora Outbreak Reaches Taco Bell (07:10) The Pitt Leads Emmy Nominations Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today’s Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Fri, 17 Jul 2026 10:00:00 -0000 full 3 Human Content, Inc. Friday, July 17, 2026 In today’s episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) and Adam Rose cover the EPCAT III trial, which found that aspirin alone was non-inferior to an initial course of rivaroxaban followed by aspirin for preventing major blood clots after elective hip or knee replacement in predominantly standard-risk patients. They examine NICE’s draft recommendation allowing two rapid endometriosis tests, EndoSure and Endotest, to enter limited NHS use while researchers gather additional real-world evidence. Plus: They discuss a recall involving more than 2.5 million bottles of prednisolone acetate eye drops, the first HAVANA Act compensation payments, the expanding Cyclospora response, and The Pitt leading the 2026 Emmy nominations with 25 nods. (00:00) Intro (01:07) Aspirin vs. Rivaroxaban After Joint Replacement (03:19) NICE Endorses Rapid Endometriosis Tests (05:30) FDA Recall of Prednisolone Eye Drops (06:07) First Havana Syndrome Payments (06:41) Cyclospora Outbreak Reaches Taco Bell (07:10) The Pitt Leads Emmy Nominations Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today’s Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Friday, July 17, 2026

In today’s episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) and Adam Rose cover the EPCAT III trial, which found that aspirin alone was non-inferior to an initial course of rivaroxaban followed by aspirin for preventing major blood clots after elective hip or knee replacement in predominantly standard-risk patients. They examine NICE’s draft recommendation allowing two rapid endometriosis tests, EndoSure and Endotest, to enter limited NHS use while researchers gather additional real-world evidence. Plus: They discuss a recall involving more than 2.5 million bottles of prednisolone acetate eye drops, the first HAVANA Act compensation payments, the expanding Cyclospora response, and The Pitt leading the 2026 Emmy nominations with 25 nods. (00:00) Intro (01:07) Aspirin vs. Rivaroxaban After Joint Replacement (03:19) NICE Endorses Rapid Endometriosis Tests (05:30) FDA Recall of Prednisolone Eye Drops (06:07) First Havana Syndrome Payments (06:41) Cyclospora Outbreak Reaches Taco Bell (07:10) The Pitt Leads Emmy Nominations

Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.

Sources & Media Attributions for Today’s Episode Available At: www.medlinespod.com/sources

Medlines is a Human Content Production

]]> 661 no Medicare's $50 GLP-1 Program, an Altered Drug Trial & Cyclospora's 18-State Spread Friday, July 10, 2026 In today's episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Eva Johnson cover the retraction of the Advocate trial after FDA reviewers found the avacopan (Tavneos) dataset was unblinded, re-adjudicated, and altered before being relocked, throwing its approval for ANCA-associated vasculitis into doubt. They break down Medicare's new GLP-1 Bridge program, which offers eligible Part D beneficiaries drugs like Wegovy and Zepbound at $50 a month through the end of 2027, and why that copay sits outside normal Part D accounting. They also track a Cyclospora outbreak now reported across 18 states and why routine washing does not reliably kill it. Plus: they also discuss Alibaba's $600 million fentanyl-precursor settlement, the WHO's first emergency-use Ebola (Bundibugyo) diagnostic, France's deadly heat wave, and more. Coverage Timeline: (00:00) Intro(01:04) Vasculitis Trial Retracted:(03:44) Medicare’s GLP‑1 Bridge(06:02) Parasite, Ebola, Heat Wave Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Fri, 10 Jul 2026 10:00:00 -0000 full 2 Human Content, Inc. Friday, July 10, 2026 In today's episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Eva Johnson cover the retraction of the Advocate trial after FDA reviewers found the avacopan (Tavneos) dataset was unblinded, re-adjudicated, and altered before being relocked, throwing its approval for ANCA-associated vasculitis into doubt. They break down Medicare's new GLP-1 Bridge program, which offers eligible Part D beneficiaries drugs like Wegovy and Zepbound at $50 a month through the end of 2027, and why that copay sits outside normal Part D accounting. They also track a Cyclospora outbreak now reported across 18 states and why routine washing does not reliably kill it. Plus: they also discuss Alibaba's $600 million fentanyl-precursor settlement, the WHO's first emergency-use Ebola (Bundibugyo) diagnostic, France's deadly heat wave, and more. Coverage Timeline: (00:00) Intro(01:04) Vasculitis Trial Retracted:(03:44) Medicare’s GLP‑1 Bridge(06:02) Parasite, Ebola, Heat Wave Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Friday, July 10, 2026


In today's episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Eva Johnson cover the retraction of the Advocate trial after FDA reviewers found the avacopan (Tavneos) dataset was unblinded, re-adjudicated, and altered before being relocked, throwing its approval for ANCA-associated vasculitis into doubt. They break down Medicare's new GLP-1 Bridge program, which offers eligible Part D beneficiaries drugs like Wegovy and Zepbound at $50 a month through the end of 2027, and why that copay sits outside normal Part D accounting. They also track a Cyclospora outbreak now reported across 18 states and why routine washing does not reliably kill it. Plus: they also discuss Alibaba's $600 million fentanyl-precursor settlement, the WHO's first emergency-use Ebola (Bundibugyo) diagnostic, France's deadly heat wave, and more.


Coverage Timeline:

(00:00) Intro
(01:04) Vasculitis Trial Retracted:
(03:44) Medicare’s GLP‑1 Bridge
(06:02) Parasite, Ebola, Heat Wave


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.

Sources & Media Attributions for Today's Episode Available At:

www.medlinespod.com/sources

Medlines is a Human Content Production

]]> 701 no ACA Enrollment Collapse, India's Chemo Crisis, & Amy Adams' Canceled CBS Show Friday, July 3, 2026 In today's inaugural episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Dr. Alok Patel (@alokpatelmd) cover a sharp drop in ACA marketplace enrollment after enhanced tax credits expired, from 24.2 million enrollees in 2025 to roughly 19.2 million in 2026 (a loss of 5 million Americans' health coverage). India is rationing two cornerstone chemotherapy drugs, cisplatin and carboplatin, after supply disruptions tied to rising platinum costs and capped essential medicine prices. A new Annals of Internal Medicine study finds older adults who received a shingles vaccine had a 24 percent lower relative risk of dementia diagnosis. Plus: heat linked to rising suicide rates in young people, the return of the 988 LGBTQ+ crisis line, and a phase 3 trial of infigratinib for achondroplasia. Coverage Timeline: (00:00) Medlines begins! (01:44) ACA enrollment drops as credits expire (03:42) India rations cisplatin & carboplatin (06:03) Shingles vaccine & dementia risk (06:38) Climate, youth suicide & 988 hotline (08:26) Amy Adams' real-life rescue Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Fri, 03 Jul 2026 10:00:00 -0000 full 1 Human Content, Inc. Friday, July 3, 2026 In today's inaugural episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Dr. Alok Patel (@alokpatelmd) cover a sharp drop in ACA marketplace enrollment after enhanced tax credits expired, from 24.2 million enrollees in 2025 to roughly 19.2 million in 2026 (a loss of 5 million Americans' health coverage). India is rationing two cornerstone chemotherapy drugs, cisplatin and carboplatin, after supply disruptions tied to rising platinum costs and capped essential medicine prices. A new Annals of Internal Medicine study finds older adults who received a shingles vaccine had a 24 percent lower relative risk of dementia diagnosis. Plus: heat linked to rising suicide rates in young people, the return of the 988 LGBTQ+ crisis line, and a phase 3 trial of infigratinib for achondroplasia. Coverage Timeline: (00:00) Medlines begins! (01:44) ACA enrollment drops as credits expire (03:42) India rations cisplatin & carboplatin (06:03) Shingles vaccine & dementia risk (06:38) Climate, youth suicide & 988 hotline (08:26) Amy Adams' real-life rescue Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production Friday, July 3, 2026


In today's inaugural episode, Dr. Will Flanary / Dr. Glaucomflecken (@drglaucomflecken) & Dr. Alok Patel (@alokpatelmd) cover a sharp drop in ACA marketplace enrollment after enhanced tax credits expired, from 24.2 million enrollees in 2025 to roughly 19.2 million in 2026 (a loss of 5 million Americans' health coverage). India is rationing two cornerstone chemotherapy drugs, cisplatin and carboplatin, after supply disruptions tied to rising platinum costs and capped essential medicine prices. A new Annals of Internal Medicine study finds older adults who received a shingles vaccine had a 24 percent lower relative risk of dementia diagnosis. Plus: heat linked to rising suicide rates in young people, the return of the 988 LGBTQ+ crisis line, and a phase 3 trial of infigratinib for achondroplasia.


Coverage Timeline:

(00:00) Medlines begins!

(01:44) ACA enrollment drops as credits expire

(03:42) India rations cisplatin & carboplatin

(06:03) Shingles vaccine & dementia risk

(06:38) Climate, youth suicide & 988 hotline

(08:26) Amy Adams' real-life rescue


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.

Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources


Medlines is a Human Content Production

]]> 754 no Healthcare News, Finally Fast Enough Struggling to stay on top of healthcare news because, well, you're too busy working in it? If only there were a way to catch up on things in less time than it takes to get prior auth approved. (Spoiler: There is.) Kick off your Fridays with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week’s most important headlines across clinical care, health policy, publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Subscribe for new episodes every Friday wherever you get your podcasts (or watch on YouTube. Medicine moves fast... So do we! Want to learn about the Medlines mission? Visit www.medlinespod.com or email medlines@human-content.com. Medlines is a Human Content Production Fri, 03 Jul 2026 00:39:00 -0000 trailer Human Content, Inc. Struggling to stay on top of healthcare news because, well, you're too busy working in it? If only there were a way to catch up on things in less time than it takes to get prior auth approved. (Spoiler: There is.) Kick off your Fridays with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week’s most important headlines across clinical care, health policy, publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Subscribe for new episodes every Friday wherever you get your podcasts (or watch on YouTube. Medicine moves fast... So do we! Want to learn about the Medlines mission? Visit www.medlinespod.com or email medlines@human-content.com. Medlines is a Human Content Production Struggling to stay on top of healthcare news because, well, you're too busy working in it? If only there were a way to catch up on things in less time than it takes to get prior auth approved. (Spoiler: There is.)

Kick off your Fridays with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week’s most important headlines across clinical care, health policy, publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals.

Subscribe for new episodes every Friday wherever you get your podcasts (or watch on YouTube.

Medicine moves fast... So do we!


Want to learn about the Medlines mission? Visit www.medlinespod.com or email medlines@human-content.com.


Medlines is a Human Content Production

]]> 149 no